aTyr Pharma Announces FDA Orphan Drug Designation
LIFE: aTyr Pharma, Inc.
2022-04-13 08:00:00
aTyr Pharma Announces FDA Orphan Drug Designation for Efzofitimod (ATYR1923) for Treatment of Systemic Sclerosis
2022-04-13 08:00:00
aTyr Pharma Announces FDA Orphan Drug Designation for Efzofitimod (ATYR1923) for Treatment of Systemic Sclerosis